FDA Approves 1st Drug For Aggressive Multiple Sclerosis

FDA Approves 1st Drug For Aggressive Multiple Sclerosis


U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed progression of the neurological disease and reduced symptoms.



from Biotech News